Observing patients with tuberculosis and related infections
Official title: Epidemiological, Demographic and Clinical Aspects of Patients With Tuberculosis, Mycobacteriosis or Infection Latent Tuberculosis
Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06764576 · Data updated 2026-11-12
This study looks at patients suspected of having tuberculosis or related infections to see how these conditions affect them and how well different tests work to diagnose them.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 13000 (estimated) |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna Academic / other |
| Locations | 1 site (Bologna) |
| Status | Recruiting |
| Started | December 19, 2021 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | January 8, 2025 |
| Trial ID | NCT06764576 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 18 years or older with a clinical or radiological suspicion of TB, non-tubercular mycobacteriosis, or latent tuberculosis infection.
✕Probably not a fit
Patients without any clinical or radiological suspicion of TB or related infections may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with clinical or radiological suspicion of tuberculosis (TB), non-tubercular mycobacteriosis, or latent tuberculosis infection (ITBL). It involves a retrospective analysis of data from January 2012 to May 2021, as well as a prospective analysis from June 2021 to December 2026. The study aims to assess the epidemiological, demographic, and clinical aspects of these patients, evaluate the diagnostic accuracy of various methods for TB and mycobacterial infections, and analyze the microbiological characteristics of the strains involved. The outcomes will help improve understanding and management of TB and related infections.
Why it matters
Potential benefit: If successful, this study could enhance the diagnosis and treatment of tuberculosis and related infections, ultimately improving patient outcomes.
How similar studies have gone: Other studies have shown success in identifying and managing tuberculosis and mycobacterial infections, making this approach relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * age of 18 years or more, * clinical/radiological suspicion of TB or non-tubercular mycobacteriosis or ITBL for which sent to the Microbiology laboratory at least one biological sample for the mycobacteria and/or a blood sample for the IGRA test; * Obtaining informed consent. Exclusion Criteria: * None
Where it's running
-
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy Recruiting
Study contacts
- Principal investigator: Paola Dal Monte, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
- Study coordinator: Paola Dal Monte, MD
- Email: paola.dalmonte@unibo.it
- Phone: 0390512145293
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Preventive TB treatment for freshmen with strong TB skin tests
This study tests whether a short course of preventive TB treatment given to freshmen with strong TB skin tests can reduce the chance of developing active TB over 3 to 4 years.
-
Portable chest X-ray screening to rapidly find TB in migrants
A community-based TB screening effort using mobile chest X-rays and AI-assisted readings is tested among migrant adults in New York City to see if it helps identify active TB earlier and connect people to care.
-
Reexamining how asymptomatic tuberculosis spreads
This project will test whether people with asymptomatic tuberculosis—particularly adults living with HIV—can pass TB to their household and close contacts.
-
Chat-based app to boost follow-up tests after abnormal chest X-ray
A chat-based mobile app (Zalo) is being tested to see if it helps people with abnormal chest X-rays in Vietnam follow through with recommended follow-up tests.
-
Respiratory health and wellbeing after pulmonary tuberculosis
See if people treated for pulmonary TB in the UK have ongoing lung problems and reduced wellbeing after finishing treatment.
-
Optimal treatment duration for radiographically apparent TB without bacteriological confirmation
This trial tests the shortest effective TB treatment duration for people found by community chest X-rays to have TB-like signs but who lack bacteriological confirmation.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.